Health Trials

Poor Ovarian Reserve

2

Review clinical trials related to Poor Ovarian Reserve. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSI

Participants will: * Take either drospirenone (a daily pill) or the standard daily injection during their ovarian stimulation cycle, alongside their regular fertility hormone injections * Undergo egg retrieval, with all resulting embryos frozen (no fresh embryo transfer in this study) * Have a frozen embryo transferred in a later cycle * Complete two short questionnaires about their treatment experience - once before starting the injections/pills, and once after the stimulation phase ends * Be followed to determine if the embryo transfer results in a pregnancy

Participants needed: 100
Trial details
Phase: Phase 1, Phase 2Age: 20-42Biological sex: FemaleType: InterventionalSponsor: Ahmed SaadUpdated: Jul 30, 2026Locations: 1
Eligibility criteria

Spontaneous menstrual cycles (21-35 days) [+5]

Contraindication to ovarian stimulation [+4]

Read more
Status: Recruiting

Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score

Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.

Participants needed: 180
Trial details
Age: 18-47Biological sex: FemaleType: InterventionalSponsor: Generation Next FertilityUpdated: Jul 9, 2025Locations: 1
Eligibility criteria

No none contraindications to IVF or PRP treatment [+2]

Anovulation due to menopause or perimenopause [+1]

Read more